FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Cardiologist: Apply Marketing Techniques to Safety Monitoring

[ Price : $8.95]

University of Colorado cardiologist David Kao says drug company marketing techniques should be used to promote drug safety in post...

FDA Orphan Status for Allos Therapy

[ Price : $8.95]

FDA grants an orphan drug designation to Allos Therapeutics for its pralatrexate, an antifolate indicated for treating patients wi...

FDA Working with WebMD on Consumer Information

[ Price : $8.95]

FDA and WebMD unveil an agreement for FDA to provide content to be carried in a distinct FDA page on WebMD and in the WebMD magazi...

Grassley Questions Heart Valve Device Approval

[ Price : $8.95]

Sen. Charles Grassley raises questions about an Edward Lifesciences heart valve repair ring that he says is being implanted in pat...

Advisors Back Coartem Approval

[ Price : $8.95]

Members of FDAs Anti-infective Advisory Committee recommend approval of Novartis Coartem for treating malaria.

Co. Execs Say DTC Ads are Industrys Worst Decision

[ Price : $8.95]

Roche and Shire senior executives blast direct-to-consumer promotion during a London financial conference.

Journal Editorials Dont Support Generic Drug Use

[ Price : $8.95]

Researchers report in JAMA that many journal editorials caution that generic cardiovascular drugs may not be equivalent to branded...

Panel Briefing Document Backs Allergan Eyelash Therapy

[ Price : $8.95]

An FDA advisory committee briefing document supports approval of Allergans Lumigan for use in improving eyelashes.

Methadone Supply Issues Resolved

[ Price : $8.95]

FDA says Xanodyne has resolved methadone HCl supply issues.

QS Problems at German Device Firm

[ Price : $8.95]

CDRH warns Stratec Medizintechnik about QS problems at its bone densitometer manufacturing facility in Germany.